We are live on ! Find out more
CG

Column Group Portfolio holdings

AUM $88.1M
1-Year Est. Return 148.03%
This Fund
S&P 500
This Quarter Est. Return
-8.63%
1 Year Est. Return
+148.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+23.89%
10 Year Est. Return
–
AUM
$707M
AUM Growth
-$337M
Cap. Flow
-$176M
Cap. Flow %
-24.84%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
NRIX icon
Nurix Therapeutics
NRIX
+$167M
2
RVMD icon
Revolution Medicines
RVMD
+$8.13M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NGM
1
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$304M 42.97%
15,396,116
– –
RAPT
2
DELISTED
RAPT Therapeutics
RAPT
$124M 17.48%
485,710
– –
RVMD icon
3
Revolution Medicines
RVMD
$43.7B
$106M 15.04%
3,347,245
-233,007
-7% -$8.13M
CNST
4
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$88.8M 12.57%
2,626,631
– –
ORIC icon
5
Oric Pharmaceuticals
ORIC
$1.44B
$84.3M 11.94%
4,768,181
– –
NRIX icon
6
Nurix Therapeutics
NRIX
$2.81B
– –
-5,383,333
Closed -$167M

Similar funds

PIS
POM Investment Strategies Raleigh, North Carolina $88.3M AUM 15.23% 1-Year Est. Return
FWM
FSR Wealth Management Elmhurst, Illinois $87.8M AUM 10.63% 1-Year Est. Return
WP
Walleye Partners Madison, Wisconsin $87.7M AUM
SHCM
Stone House Capital Management Bay Harbor Islands, Florida $88.5M AUM 149.16% 1-Year Est. Return
YIM
Yoffe Investment Management Lemoyne, Pennsylvania $87.4M AUM 30.8% 1-Year Est. Return
VPW
Variant Private Wealth Tysons, Virginia $88.9M AUM 25.07% 1-Year Est. Return
LC
Luminist Capital Grand Rapids, Michigan $89M AUM 17.66% 1-Year Est. Return
BI
Bradyco Inc Cambridge, Massachusetts $87.2M AUM 8.85% 1-Year Est. Return

Column Group's Q2 2021 Portfolio in Review

As of Q2 2021, Column Group held 6 positions worth $707M, down 32% from $1.04B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Column Group withdrew a net $176M in Q2 2021, closing 1 position and reducing 1 holding. Its most notable exit was Nurix Therapeutics, an estimated $167M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Column Group's biggest Q2 2021 reduction was Revolution Medicines, cutting an estimated $8.13M.
  • Column Group fully exited Nurix Therapeutics in Q2 2021, selling an estimated $167M.
  • Column Group's ten largest holdings make up 100% of its $707M portfolio in Q2 2021.
  • Column Group opened 0 new positions and closed 1 in Q2 2021.
  • Column Group's portfolio value fell 32% quarter-over-quarter to $707M.

Based on Column Group's 13F filing for Q2 2021, filed 16 Aug 2021.